Selma Tobudic - Infectious Diseases

Author Information

Selma Tobudic is affiliated with the Division of Infectious Diseases and Tropical Medicine at the Department of Medicine I, Medical University of Vienna, located at Waehringer Guertel 18-20, 1090, Vienna, Austria. Her work primarily revolves around infectious diseases, with a particular focus on the immunological aspects of vaccination and responses in various patient populations.

Research Contributions

Selma Tobudic has made significant contributions to the field of infectious diseases, with a notable focus on the immunogenicity of COVID-19 vaccinations among vulnerable populations such as hematological patients, hemato-oncological patients, and those with autoimmune diseases. Her research explores the efficacy and immune response of both homologous and heterologous booster vaccinations in immunosuppressed patients, particularly in the context of the SARS-CoV-2 pandemic. Additionally, she has investigated the challenges posed by breakthrough infections in cancer patients and unique presentations of infectious diseases in travelers, such as furuncular myiasis and delayed malaria diagnosis.

Aliases

Selma Tobudic is also known by the aliases S Tobudic and S. Tobudic.

Publication and Citation Metrics

Citation Count	1831
h-index	23
Paper Count	87

Publications:

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination

DOI: 10.3390/cancers14081962

Year: 2022

Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study

DOI: 10.1016/j.ejca.2022.01.019

Year: 2022

SARS-CoV-2 vaccine response in patients with autoimmune hepatitis

DOI: 10.1016/j.cgh.2022.04.006

Year: 2022

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial

DOI: 10.1136/annrheumdis-2021-221558

Year: 2022

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron

DOI: 10.1016/j.ccell.2022.04.003

Year: 2022

B Cell Depletion and SARS‐CoV‐2 Vaccine Responses in Neuroimmunologic Patients

DOI: 10.1002/ana.26309

Year: 2022

The swollen lip: Unusual presentation of furuncular myiasis in a returning traveller.

DOI: 10.1093/jtm/taac008

Year: 2022

Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study

DOI: 10.1136/annrheumdis-2021-221788

Year: 2022

Pandemic-related delay of falciparum malaria diagnosis in a traveler leading to cerebral malaria

DOI: 10.1093/jtm/taab159

Year: 2021

Renal Abscess: A Rare Complication of Paratyphoid Fever in an Immunocompetent Traveler from Southeast Asia

DOI: 10.4269/ajtmh.21-0368

Year: 2021

How Do Epidemiologists Track Infectious Diseases?

How Can Genomics Improve Diagnostics?

What is Protein Targeting?

What is Antimicrobial Resistance?

What Are Some Success Stories of One Health in Action?

Can Inherited Immunity Be Enhanced?

Are There Specific Hygiene Recommendations for Food Safety?

What Challenges Do Surveillance Systems Face?

Can Respiratory Symptoms Be Prevented?

How do Structural Proteins Aid in Viral Assembly?

Partnered Content Networks

Relevant Topics